Gschwantler, Michael

Publishing since 1993 (Senior)

Has published 41 publications in 18 years

Number of publications published per year by Gschwantler, Michael. (Source : PubMed)

Distribution of publications types for Gschwantler, Michael. (Source : PubMed)
(a publication can be of different types, so total may exceed publications count)

Recent publications

•  Ferenci P, Laferl H, Scherzer TM, Maieron A, Hofer H, Stauber R, Gschwantler M, Brunner H, Wenisch C, Bischof M, Strasser M, Datz C, Vogel W, Löschenberger K, Steindl-Munda P. Peginterferon alfa-2a/ribavirin for 48 or 72 weeks in hepatitis C genotypes 1 and 4 patients with slow virologic response.  Gastroenterology  2010;138;2  
•  Ordubadi P, Gschwantler M. Peginterferon plus ribavirin over two years may be successful in patients with chronic hepatitis C and a very slow virologic response.  Scand. J. Gastroenterol.  2009;44;9  
•  Ordubadi P, Blaha B, Schmid A, Krampla W, Hinterberger W, Gschwantler M. Capsule endoscopy with retention of the capsule in a duodenal diverticulum.  Endoscopy  2008;40 Suppl 2  
•  Ferenci P, Laferl H, Scherzer TM, Gschwantler M, Maieron A, Brunner H, Stauber R, Bischof M, Bauer B, Datz C, Löschenberger K, Formann E, Staufer K, Steindl-Munda P. Peginterferon alfa-2a and ribavirin for 24 weeks in hepatitis C type 1 and 4 patients with rapid virological response.  Gastroenterology  2008;135;2  
•  Ferenci P, Brunner H, Laferl H, Scherzer TM, Maieron A, Strasser M, Fischer G, Hofer H, Bischof M, Stauber R, Gschwantler M, Steindl-Munda P, Staufer K, Löschenberger K. A randomized, prospective trial of ribavirin 400 mg/day versus 800 mg/day in combination with peginterferon alfa-2a in hepatitis C virus genotypes 2 and 3.  Hepatology  2008;47;6  
•  Jessner W, Gschwantler M, Formann E, Gurguta C, Watkins-Riedel T, Wrba F, Ferenci P. Very early viral kinetics on interferon treatment in chronic hepatitis C virus genotype 4 infection.  Antivir. Ther. (Lond.)  2008;13;4  
•  Jessner W, Watkins-Riedel T, Müller C, Formann E, Gschwantler M, Ferenci P. Comparison of the Bayer VERSANT HCV RNA 3.0 and the Roche COBAS Amplicor HCV Monitor, Version 2.0, assays in HCV genotype 4 infection.  J. Viral Hepat.  2007;14;11  
•  Singer E, Gschwantler M, Plattner D, Kriwanek S, Armbruster C, Schueller J, Feichtinger H, Roka R, Moeschl P, Weiss W, Kroiss A. Differential diagnosis of benign and malign pancreatic masses with 18F-fluordeoxyglucose-positron emission tomography recorded with a dual-head coincidence gamma camera.  Eur J Gastroenterol Hepatol  2007;19;6  
•  Dzirlo L, Hubner M, Müller C, Blaha B, Formann E, Dellinger C, Petzelbauer P, Müllauer L, Huber K, Kneussl M, Gschwantler M. A mimic of sarcoidosis.  Lancet  2007;369;9575  
•  Dzirlo L, Blaha B, Müller C, Hubner M, Kneussl M, Huber K, Gschwantler M. Capsule endoscopic appearance of the small-intestinal mucosa in Whipple's disease and the changes that occur during antibiotic therapy.  Endoscopy  2007;39 Suppl 1  

[ See timeline ] [ See all publications ]